Financial News
Adverum Biotechnologies, Inc. - Common Stock (NQ: ADVM )
4.460
+0.170
(+3.96%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Headline News about Adverum Biotechnologies, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 05, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/08/01/wall-street-chart-shutter2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/07/19/Image44.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/07/17/ADVM.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/07/17/movers-image_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/07/17/Movers.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/03/20/image_4.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2021/08/penny-stocks-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2024/01/growthstocks1600-2.png)
![](https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-lifting-men-figurines.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Eyes_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/05/image32.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
February 05, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/Genetic-Research-And-Biotech-Science-Con_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 05, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/06/advm.png?width=1200&height=800&fit=crop)
Why Is Eye Disease-Focused Adverum Bio Stock Trading Higher Today?
November 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/06/12/diversified_healthcare_trust_-_logo_copy.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 28, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19961.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/bz-pharma_3.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/14/bz-pharma_1.jpg?width=1200&height=800&fit=crop)
Adverum Commences Mid-Stage Chronic Eye Disorder Candidate Study
September 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_15685.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/18/image12.jpg?width=1200&height=800&fit=crop)
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.